Target intelligence / Profile preview

StAR-related lipid transfer protein 3 (STARD3) (STARD3)

Target
STARD3
Molecular classification
Transporter, Other
01

Overview

StAR-related lipid transfer protein 3 (STARD3), also known as metastatic lymph node 64 (MLN64), is a late endosomal integral membrane protein that plays a critical role in non-vesicular cholesterol transport. It creates membrane contact sites between the endoplasmic reticulum and late endosomes, facilitating the movement of cholesterol between these compartments. STARD3 is frequently overexpressed or co-amplified with HER2/ERBB2 in various malignancies, including breast, gastric, colorectal, and prostate cancers, where it promotes cell proliferation, migration, and invasion by altering membrane cholesterol distribution and tight junction organization. Consequently, STARD3 has emerged as an attractive therapeutic target in oncology. Pharmacological inhibitors, such as the first-in-class compound VS1, as well as repurposed drugs like digoxin and bexarotene (Targretin), target its cholesterol-binding START domain to disrupt cholesterol trafficking and attenuate cancer progression. However, targeting STARD3 presents safety concerns, including potential disruption of epithelial barrier function and cellular lipid homeostasis.

Other names
Metastatic lymph node gene 64 proteinMLN64Protein CAB1START domain-containing protein 3StARD3Metastatic lymph node 64
02

Mechanism of action

Inhibition of the START domain to block non-vesicular cholesterol transport

03

Biological functions

Cell proliferationOther
04

Disease associations

CancerNeurodegenerative diseaseOther
05

Safety considerations

Impairment of epithelial barrier functionDisruption of cellular lipid homeostasisMitochondrial dysfunction
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

STARD3 expressionHER2/ERBB2 amplificationZO-1 protein expression

Beyond the preview

Go deeper on StAR-related lipid transfer protein 3 (STARD3) (STARD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StAR-related lipid transfer protein 3 (STARD3) (STARD3).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call